| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.2 | 6e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.18 | 0.0009 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.094 | 0.05 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.093 | 0.06 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.059 | 0.2 |